The Administrative Core, led by Dr. Pascal Poignard, will provide general management and administrative support for all Projects and Cores under the U-19 Grant. Additionally, this Core will coordinate an Administrative Partnership Plan to maintain timely and good communications across various external researchers, advisors and stakeholders related to HIV B cell immunology. These goals will be met by completing the following Specific Aims: General Management and Administration 1. Maintain good Project and Core integration via coordinated project management to track progress, troubleshoot problems and facilitate achievement of grant goals;regular intra-grant communication via annual meetings, teleconferences/web conferences, and establishment of a web-enabled project portal;and the timely review of data and progress with key scientific and grant partners. 2. Ensure that lAVI administrative resources are accessed and in place for financial management, grants management, business development and intellectual property management. Administrative Partnership Plan 3. Establish an External Scientific Advisory Panel (ESAP) which will conduct an annual review of progress, provide scientific input and ensure timely and proper reporting to NIH/NIH Program Officials. 4. Host and actively participate in annual B cell Immunology Partnership Program for HIV-1 Vaccine Discovery Workshops to ensure dissemination and collaboration with other U-19 grantees, other NIH grantees and HIV researchers in the area of B cell immunology.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI090970-04
Application #
8526369
Study Section
Special Emphasis Panel (ZAI1-PTM-A)
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
4
Fiscal Year
2013
Total Cost
$58,751
Indirect Cost
$3,542
Name
International AIDS Vaccine Initiative
Department
Type
DUNS #
020790895
City
New York
State
NY
Country
United States
Zip Code
Little, Susan J; Kosakovsky Pond, Sergei L; Anderson, Christy M et al. (2014) Using HIV networks to inform real time prevention interventions. PLoS One 9:e98443
Hepler, N Lance; Scheffler, Konrad; Weaver, Steven et al. (2014) IDEPI: rapid prediction of HIV-1 antibody epitopes and other phenotypic features from sequence data using a flexible machine learning platform. PLoS Comput Biol 10:e1003842
Gianella, Sara; Massanella, Marta; Richman, Douglas D et al. (2014) Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment. J Virol 88:7818-27
Wagner, Gabriel A; Pacold, Mary E; Kosakovsky Pond, Sergei L et al. (2014) Incidence and prevalence of intrasubtype HIV-1 dual infection in at-risk men in the United States. J Infect Dis 209:1032-8
Chaillon, A; Gianella, S; Massanella Luna, M et al. (2014) A case cluster demonstrating the relationship between HLA concordance and virologic and disease outcomes in human immunodeficiency virus infection. Virology 449:104-8
Crotty, Shane (2014) T follicular helper cell differentiation, function, and roles in disease. Immunity 41:529-42
Ogunniyi, Adebola O; Thomas, Brittany A; Politano, Timothy J et al. (2014) Profiling human antibody responses by integrated single-cell analysis. Vaccine 32:2866-73
Sok, Devin; Doores, Katie J; Briney, Bryan et al. (2014) Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV. Sci Transl Med 6:236ra63
King, Helen L; Keller, Samuel B; Giancola, Michael A et al. (2014) Pre-exposure prophylaxis accessibility research and evaluation (PrEPARE Study). AIDS Behav 18:1722-5
Choi, Youn Soo; Eto, Danelle; Yang, Jessica A et al. (2013) Cutting edge: STAT1 is required for IL-6-mediated Bcl6 induction for early follicular helper cell differentiation. J Immunol 190:3049-53

Showing the most recent 10 out of 21 publications